These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 14363131)

  • 21. Amino acids are not un-charged (lipid-soluble) substances. Why we might as well forget pyroglutamate as an amino acid.
    Christensen HN
    Trends Pharmacol Sci; 1988 Dec; 9(12):430. PubMed ID: 3273495
    [No Abstract]   [Full Text] [Related]  

  • 22. Demonstration of a pyroglutamyl residue at the N terminus of the B-chain of porcine relaxin.
    Schwabe C; McDonald JK
    Biochem Biophys Res Commun; 1977 Feb; 74(4):1501-4. PubMed ID: 843375
    [No Abstract]   [Full Text] [Related]  

  • 23. Excretion of D-pyrrolidone carboxylic acid by rat and dog fed with tumour proteins.
    KOGL F; BARENDREGT TJ; KLEIN AJ
    Nature; 1948 Nov; 162(4123):732. PubMed ID: 18933601
    [No Abstract]   [Full Text] [Related]  

  • 24. Enzymatic formation of L-pyrrolidone carboxylic acid in mammalian epidermis and other tissues.
    Wolfersberger MG; Tabachnick J
    J Invest Dermatol; 1974 Jun; 62(6):587-90. PubMed ID: 4835780
    [No Abstract]   [Full Text] [Related]  

  • 25. Letter: Reduced amounts of pyroglutamic acid in scales from psoriatic plaques.
    Marstein S; Jellum E; Eldjarn L
    Arch Dermatol; 1973 Oct; 108(4):578-9. PubMed ID: 4745297
    [No Abstract]   [Full Text] [Related]  

  • 26. The concentration of pyroglutamic acid (2-pyrrolidone-5-carboxylic acid) in normal and psoriatic epidermis, determined on a microgram scale by gas chromatography.
    Marstein S; Jellum E; Eldjarn L
    Clin Chim Acta; 1973 Dec; 49(3):389-95. PubMed ID: 4776481
    [No Abstract]   [Full Text] [Related]  

  • 27. Determination of asparagine, glutamine and pyrrolidonecarboxylic acid in total enzymic hydrolysates of peptides and glycopeptides by gas-liquid chromatography.
    Hediger H; Stevens L; Bradenberger H; Schmid K
    Biochem J; 1973 Jul; 133(3):551-61. PubMed ID: 4733240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzymatic formation of L- & D-2-pyrrolidone 5-carboxylic acid from L- & D-glutamic acid in human skin & albino rat epidermis.
    Sule SM; Mathur GP
    Indian J Biochem Biophys; 1972 Mar; 9(1):55-8. PubMed ID: 4642359
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition of growth of hamster tumor cells in vitro by pyrrolidone carboxylic acid in a glutamine-dependent system.
    Goetz IE; Weinstein C; Roberts E
    In Vitro; 1973; 8(4):279-82. PubMed ID: 4734901
    [No Abstract]   [Full Text] [Related]  

  • 30. A modified colorimetric method for the determination of pyrrolidone carboxylyl peptidase activity in bacteria.
    Exterkate FA
    Anal Biochem; 1973 May; 53(1):321-6. PubMed ID: 4711108
    [No Abstract]   [Full Text] [Related]  

  • 31. Pyrrolidone carboxylic acid in acute and chronic alcoholism. Preclinical and clinical studies.
    Pellegrini-Giampietro DE; Moroni F; Pistelli A; Palmerani B; Zorn AM; Peruzzi S; Caramelli L; Botti P; Valenza T; Antonini M
    Recenti Prog Med; 1989 Mar; 80(3):160-4. PubMed ID: 2740606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A CONVENIENT PROCEDURE FOR THE DETERMINATION OF PYRROLIDONECARBOXYLIC ACID AND RELATED COMPOUNDS.
    POLGAR P; MEISTER A
    Anal Biochem; 1965 Aug; 12():338-43. PubMed ID: 14340027
    [No Abstract]   [Full Text] [Related]  

  • 33. [On the ring substituted 1-acrylpyrrolidine- and 1-acyl-2-pyrroline-4-carboxylic acids and their anti-inflammatory activity].
    Kejha J; Nĕmecek O; Grimová J; Kakác B
    Cesk Farm; 1976 Sep; 25(7):258-65. PubMed ID: 991286
    [No Abstract]   [Full Text] [Related]  

  • 34. FR-900148, a new antibiotic. II. Structure determination of FR-900148.
    Kuroda Y; Okuhara M; Goto T; Okamoto M; Yamashita M; Kohsaka M; Aoki H; Imanaka H
    J Antibiot (Tokyo); 1980 Mar; 33(3):267-71. PubMed ID: 7380738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Radiotracer of the distribution of a new psychotropic agent in mice: L-2-pyrrolidone-5-carboxylate of dimethylaminoethanol. I. Comparison with L-glutamic and L-2 pyrrolidone-5-carboxylic acids].
    Chanal JL; Marignan R; Cousse H; Baldet M
    Therapie; 1972; 27(1):35-46. PubMed ID: 5017555
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of pyridoxine-pyrrolidone-carboxylate on hepatic adenosine triphosphate levels in rats.
    Baldacci M; Catalani R; Bartoli C; Mura U
    Boll Soc Ital Biol Sper; 1982 Dec; 58(24):1643-9. PubMed ID: 7168788
    [No Abstract]   [Full Text] [Related]  

  • 37. [Neuroprotective properties of pyroglutamic acid in combination with pyrrolidone].
    Lun'shina EV; Gan'shina TS; Makarova LM; Pogorelyĭ VE; Mirzoian RS
    Eksp Klin Farmakol; 2003; 66(1):20-2. PubMed ID: 12683075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experimental study of some pharmacodynamic properties of magnesium 2-pyrrolidone-5-carboxylate].
    Binet P; Miocque M; Pechery C; Roux M; Rinjard P
    Therapie; 1976; 31(4):471-81. PubMed ID: 137552
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hepatic damage caused by drugs and evaluation of the therapeutic effectiveness of pyridoxine pyrrolidone carboxylate].
    Nami R
    Clin Ter; 1979 Oct; 91(1):41-55. PubMed ID: 546575
    [No Abstract]   [Full Text] [Related]  

  • 40. Accumulation of 5-oxoproline in mouse tissues after inhibition of 5-oxoprolinase and administration of amino acids: evidence for function of the gamma-glutamyl cycle.
    Van Der Werf P; Stephani RA; Meister A
    Proc Natl Acad Sci U S A; 1974 Apr; 71(4):1026-9. PubMed ID: 4151516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.